Wei J, Shaw L M, Mercurio A M
Department of Medicine (GI Division), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Biol Chem. 1998 Mar 6;273(10):5903-7. doi: 10.1074/jbc.273.10.5903.
We examined the possibility that the alpha6A and alpha6B cytoplasmic domain variants of the alpha6beta1 integrin differentially activate p42 and p44 mitogen-activated protein (MAP) kinases. P388D1 macrophages that express equivalent surface levels of either the alpha6Abeta1 or alpha6Bbeta1 integrin were used to examine this issue. Adhesion to laminin-1 mediated by the alpha6Abeta1 integrin triggered activation of a substantial fraction of total p42 and p44 MAP kinases as assessed using a mobility shift assay, immunoblot analysis with a phosphospecific MAP kinase antibody, and an immune complex kinase assay. In contrast, ligation of the alpha6Bbeta1 integrin did not trigger significant MAP kinase activation. These data were confirmed by antibody clustering of the alpha6beta1 integrins. Both the alpha6Abeta1 and alpha6Bbeta1 integrins were capable of activating the p70 ribosomal S6 kinase and this activation, unlike MAP kinase activation, is dependent on phosphoinositide 3-OH kinase. Activation of MAP kinase by alpha6beta1 requires both Ras and protein kinase C activity. A functional correlate for differential activation of MAP kinase was provided by the findings that the alpha6Abeta1 transfectants migrated significantly better on laminin than the alpha6Bbeta1 transfectants and this migration was dependent on MAP kinase activity based on the use of the MAP kinase kinase (MEK1) inhibitor PD98059. Our findings demonstrate that the alpha6beta1 integrin can activate MAP kinase, that this activation is regulated by the cytoplasmic domain of the alpha6 subunit, and that it relates to alpha6beta1-mediated migration.
我们研究了α6β1整合素的α6A和α6B胞质结构域变体是否差异激活p42和p44丝裂原活化蛋白(MAP)激酶的可能性。使用表达等量α6Aβ1或α6Bβ1整合素表面水平的P388D1巨噬细胞来研究这个问题。通过迁移率变动分析、使用磷酸化特异性MAP激酶抗体的免疫印迹分析以及免疫复合物激酶分析评估,由α6Aβ1整合素介导的与层粘连蛋白-1的粘附触发了相当一部分总p42和p44 MAP激酶的激活。相比之下,α6Bβ1整合素的连接未触发显著的MAP激酶激活。这些数据通过α6β1整合素的抗体聚集得到证实。α6Aβ1和α6Bβ1整合素都能够激活p70核糖体S6激酶,并且这种激活与MAP激酶激活不同,依赖于磷酸肌醇3 - OH激酶。α6β1对MAP激酶的激活需要Ras和蛋白激酶C的活性。α6Aβ1转染细胞在层粘连蛋白上的迁移明显优于α6Bβ1转染细胞,并且基于使用MAP激酶激酶(MEK1)抑制剂PD98059,这种迁移依赖于MAP激酶活性,这一发现为MAP激酶的差异激活提供了功能相关性。我们的研究结果表明,α6β1整合素可以激活MAP激酶,这种激活受α6亚基的胞质结构域调节,并且与α6β1介导的迁移有关。